MabSwitch Inc. specializes in innovative biotechnological solutions, focusing on the development of monoclonal antibodies and their applications in therapeutic treatments. The company employs advanced protein engineering techniques to enhance the efficacy and specificity of its antibody products. Their proprietary platform allows for the design of antibodies that can be precisely tailored to target specific disease markers, thereby improving treatment outcomes for various conditions, including cancer and autoimmune disorders.

In addition to their antibody development, MabSwitch Inc. utilizes cutting-edge technologies in the field of drug delivery systems. These systems are designed to optimize the distribution and release of therapeutic agents, ensuring that they reach their intended targets effectively. The integration of these technologies not only enhances the performance of their therapeutic products but also aims to minimize side effects, making treatments safer and more effective for patients. Through continuous research and development, MabSwitch Inc. is committed to advancing the field of biomedicine and providing innovative solutions for unmet medical needs.

United States

We develop regulatable antibodies that vastly improve patient outcomes resulting from their application as next-generation immunotherapeutics, diagnostics and immunoaffinity reagents

MabSwitch Inc

Company Details